Baicalein, Oroxylum indicum, Phosphodiesterase 5 inhibitor, Pulmonary artery, Vasorelaxant
Quinazoline derivatives, PDE5, vasorelaxation, rat pulmonary artery, cytotoxicity, CYP activities